| __timestamp | Cytokinetics, Incorporated | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 44426000 | 22732000 |
| Thursday, January 1, 2015 | 46398000 | 29245000 |
| Friday, January 1, 2016 | 59897000 | 33206000 |
| Sunday, January 1, 2017 | 90296000 | 31152000 |
| Monday, January 1, 2018 | 89135000 | 10136000 |
| Tuesday, January 1, 2019 | 86125000 | 45546000 |
| Wednesday, January 1, 2020 | 96951000 | 43367000 |
| Friday, January 1, 2021 | 159938000 | 81413000 |
| Saturday, January 1, 2022 | 240813000 | 139304000 |
| Sunday, January 1, 2023 | 330123000 | 192361000 |
| Monday, January 1, 2024 | 159417000 |
In pursuit of knowledge
In the dynamic world of biotechnology, understanding cost structures is crucial for investors and stakeholders. Over the past decade, Halozyme Therapeutics, Inc. and Cytokinetics, Incorporated have shown distinct trajectories in their cost of revenue. From 2014 to 2023, Cytokinetics experienced a staggering 643% increase in costs, peaking in 2023. This reflects their aggressive expansion and investment in research and development. In contrast, Halozyme's costs rose by 747% over the same period, indicating a strategic shift towards scaling operations. Notably, 2021 marked a pivotal year for both companies, with Cytokinetics' costs surging by 65% and Halozyme's by 88% compared to the previous year. These trends highlight the evolving strategies of these biotech giants as they navigate the competitive landscape. Investors should watch these cost trends closely, as they offer insights into each company's growth strategy and market positioning.
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Cytokinetics, Incorporated
Cost of Revenue Trends: Neurocrine Biosciences, Inc. vs Halozyme Therapeutics, Inc.
Analyzing Cost of Revenue: Intra-Cellular Therapies, Inc. and Halozyme Therapeutics, Inc.
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.'s Expenses
Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Viridian Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Cytokinetics, Incorporated vs Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Supernus Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Geron Corporation
Cytokinetics, Incorporated vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored